Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biocryst Pharma Inc (NQ: BCRX )

7.050 -0.220 (-3.03%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,816,325
Open 7.270
Bid (Size) 7.040 (765)
Ask (Size) 7.050 (5)
Prev. Close 7.270
Today's Range 7.040 - 7.310
52wk Range 4.030 - 7.950
Shares Outstanding 185,583,896
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Insider-Buy Stocks to Add to Your Watchlist Now
Insiders are buying these stocks that should be on your radar, but only two are set up to rebound and move higher today; the third may move lower first. 
Via MarketBeat
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga

Performance

YTD
+16.14%
+16.14%
1 Month
+12.98%
+12.98%
3 Month
+53.93%
+53.93%
6 Month
+18.29%
+18.29%
1 Year
-1.67%
-1.67%

More News

Read More
A Preview Of BioCryst Pharma's Earnings
Via Benzinga
What's Going On With BioCryst Pharmaceuticals Stock?
Via Benzinga
Where BioCryst Pharma Stands With Analysts
Via Benzinga
What 7 Analyst Ratings Have To Say About BioCryst Pharma
Via Benzinga
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Why BioCryst Pharmaceuticals Vaulted Nearly 20% Higher on Monday
Via The Motley Fool
BioCryst Pharmaceuticals 'Fantastic' Q1 Earnings Rides On Outstanding Orladeyo Performance
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q1 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Perficient Shares Are Trading Higher By Around 53%? Here Are 20 Stocks Moving In Monday's Mid-Day Session
Via Benzinga
BCRX Stock Earnings: BioCryst Pharma Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
Via InvestorPlace
BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
What's Going On With BioCryst Stock After Earnings?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For February 26, 2024
Via Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
Via Benzinga
3 Magnificent Growth Stocks to Buy on the Dip
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023
Via Benzinga
BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.